Skip to main content

Syndicate contenthepatitis B

Statement of ESHRE on the European Commission proposal of viral screening

With 900,000 assisted reproduction treatments annually such as IVF and intrauterine inseminations in Europe the Commission's proposal to screen both partners before each treatment could lead to costs of over EUR 140 million annually.

Hepatitis B does not increase risk for pancreatic cancer

DETROIT -- A Henry Ford Hospital study found that hepatitis B does not increase the risk for pancreatic cancer -- and that only age is a contributing factor.

Elevated lymphotoxin expression in liver leads to chronic hepatitis and causes HCC

A recent study maps the pathway that leads from infection with Hepatitis B and C virus (HBV and HCV) to chronic hepatitis and liver cancer and proposes a new therapeutic strategy for treating liver diseases with chronic inflammation.

HBV genotype B/B3 and C/C1 are the major genotypes in Indonesia?

Previous studies revealed that HBV genotypes as well as mutations in the core promoter, precore or HBx gene have been shown to have an association with the clinical outcome of liver disease, however, this is still controversial. It is likely that this depends on the HBV genotype distribution in certain region.

New 'adjuvant' could hold future of vaccine development

CORVALLIS, Ore. -- Scientists at Oregon State University have developed a new "adjuvant" that could allow the creation of important new vaccines, possibly become a universal vaccine carrier and help medical experts tackle many diseases more effectively.

Racial disparity studied in patients undergoing liver transplantation for hepatitis B

According to the Centers for Disease Control and Prevention (CDC) 1.5 to 2 million Americans are infected with the hepatitis B virus (HBV). Prior studies have shown there to be significant racial differences in access to and outcomes of liver transplantation. Recently, doctors from across the U.S.

Genetically engineered bacteria are sweet success against IBD

For the first time, scientists have used a genetically engineered "friendly" bacterium to deliver a therapy.

Wistar scientists find key to strengthening immune response to chronic infection

PHILADELPHIA -- (August 6, 2009) -- A team of researchers from The Wistar Institute has identified a protein that could serve as a target for reprogramming immune system cells exhausted by exposure to chronic viral infection into more effective "soldiers" against certain viruses like HIV, hepatitis C, and hepatitis B, as well as some cancers, such as melanoma.

SAMe is effective in preventing formation of primary liver cancer in rats

A new study investigated the effectiveness of S-adenosylmethionine (SAMe) in the prevention and treatment of hepatocellular carcinoma (HCC) or primary liver cancer. SAMe, a widely available nutritional supplement, with little known side effects, was found to be effective in preventing the formation of HCC in rats.

Pre-chewed food could transmit HIV

(MEMPHIS, Tenn. -- July 21, 2009) Researchers have uncovered the first cases in which HIV almost certainly was transmitted from mothers or other caregivers to children through pre-chewed food. The source of HIV in the pre-chewed food was most likely the infected blood in the saliva of the people who pre-chewed the food before giving it to the children.

Low-fat diet helps genetically predisposed animals avoid liver cancer

PHILADELPHIA -- In a study comparing two strains of mice, one susceptible to developing cancer and the other not, researchers found that a high-fat diet predisposed the cancer-susceptible strain to liver cancer, and that by switching to a low-fat diet early in the experiment, the same high-risk mice avoided the malignancy.

Study shows promise for new cancer-stopping therapy

Researchers at Nationwide Children's Hospital and Johns Hopkins University have discovered that delivering a small molecule that is highly expressed in normal tissues but lost in diseased cells can result in tumor suppression.

NEJM study points to new era in hepatitis C treatment

NEW YORK (June 4, 2009) -- For patients with the most common form of hepatitis C, the addition of a hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone.

Advances being made in the treatment of hepatitis

CHICAGO, IL (June 2, 2009) -- Researchers are making great strides in the development of new treatments for hepatitis and in confirming the effectiveness of current treatments, according to several studies being presented at Digestive Disease Week® 2009 (DDW®).

Parents of internationally adopted children advised to verify children's immunization levels

CLEVELAND - May 5, 2009 - A study by the division of global child health at Case Western Reserve University School of Medicine cautions adoptive parents not to rely solely on vaccination records when gauging their internationally adopted children's immunizations.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes